C4 therapeutics added to nasdaq biotechnology index

Watertown, mass., dec. 17, 2021 (globe newswire) -- c4 therapeutics, inc. (c4t) (nasdaq: cccc), a clinical-stage biopharmaceutical company pioneering a new class of small-molecule medicines that selectively destroy disease-causing proteins through degradation, today announced its inclusion on the nasdaq biotechnology index (nasdaq: nbi), effective on december 20, 2021.

CCCC Ratings Summary

CCCC Quant Ranking